Ad is loading...
NUMD
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
NVYTF
Price
$0.66
Change
-$0.00 (-0.00%)
Updated
Nov 8 closing price
Ad is loading...

NUMD vs NVYTF

Header iconNUMD vs NVYTF Comparison
Open Charts NUMD vs NVYTFBanner chart's image
Nu-Med Plus
Price$0.02
Change-$0.00 (-0.00%)
Volume$22.35K
CapitalizationN/A
Novacyt Clamart
Price$0.66
Change-$0.00 (-0.00%)
Volume$245
CapitalizationN/A
NUMD vs NVYTF Comparison Chart
Loading...
View a ticker or compare two or three
VS
NUMD vs. NVYTF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUMD is a Hold and NVYTF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (NUMD: $0.02 vs. NVYTF: $0.66)
Brand notoriety: NUMD and NVYTF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NUMD: 62% vs. NVYTF: 41%
Market capitalization -- NUMD: $1.46M vs. NVYTF: $56.79M
NUMD [@Medical Specialties] is valued at $1.46M. NVYTF’s [@Medical Specialties] market capitalization is $56.79M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUMD’s FA Score shows that 2 FA rating(s) are green whileNVYTF’s FA Score has 0 green FA rating(s).

  • NUMD’s FA Score: 2 green, 3 red.
  • NVYTF’s FA Score: 0 green, 5 red.
According to our system of comparison, NUMD is a better buy in the long-term than NVYTF.

Price Growth

NUMD (@Medical Specialties) experienced а -0.03% price change this week, while NVYTF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

NUMD is expected to report earnings on May 10, 2023.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
NVYTF($56.8M) has a higher market cap than NUMD($1.46M). NVYTF YTD gains are higher at: -11.374 vs. NUMD (-55.970). NUMD has higher annual earnings (EBITDA): -94.1K vs. NVYTF (-1.71M). NVYTF has more cash in the bank: 102M vs. NUMD (53K). NUMD has less debt than NVYTF: NUMD (100K) vs NVYTF (1.87M). NVYTF has higher revenues than NUMD: NVYTF (95.8M) vs NUMD (0).
NUMDNVYTFNUMD / NVYTF
Capitalization1.46M56.8M3%
EBITDA-94.1K-1.71M6%
Gain YTD-55.970-11.374492%
P/E RatioN/A1.33-
Revenue095.8M-
Total Cash53K102M0%
Total Debt100K1.87M5%
FUNDAMENTALS RATINGS
NUMD: Fundamental Ratings
NUMD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTEX28.83-0.11
-0.38%
Open Text Corp
AMN23.70-0.17
-0.71%
AMN Healthcare Services
CLEU0.21N/A
-1.90%
China Liberal Education Holdings Limited
KRT29.48-0.80
-2.64%
Karat Packaging
AREC0.90-0.14
-13.34%
American Resources Corp

NUMD and

Correlation & Price change

A.I.dvisor tells us that NUMD and NNCSF have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NUMD and NNCSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUMD
1D Price
Change %
NUMD100%
-5.37%
NNCSF - NUMD
17%
Poorly correlated
N/A
NVYTF - NUMD
10%
Poorly correlated
N/A
OSSUY - NUMD
9%
Poorly correlated
N/A
NSTM - NUMD
5%
Poorly correlated
N/A
OCPNF - NUMD
3%
Poorly correlated
-1.49%
More

NVYTF and

Correlation & Price change

A.I.dvisor tells us that NVYTF and ARAY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVYTF and ARAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVYTF
1D Price
Change %
NVYTF100%
N/A
ARAY - NVYTF
31%
Poorly correlated
-2.30%
MBGNF - NVYTF
28%
Poorly correlated
N/A
PRCT - NVYTF
21%
Poorly correlated
+3.53%
NUMD - NVYTF
10%
Poorly correlated
-5.37%
ODYY - NVYTF
8%
Poorly correlated
-13.51%
More